At the request of stakeholders, the Canadian Agency for Drugs and Technologies in Health (CADTH), through its Canadian Optimal Medication Prescribing and Utilization Service (COMPUS), is extending the feedback deadline on our economic insulin analogues report from December 21, 2007 to January 11, 2008.
Please provide your input on our draft report: Economic Evaluation of Insulin Analogues for the Treatment of Patients With Type 1 and Type 2 Diabetes Mellitus in Canada by January 11, 2008.
The objective of this economic assessment is to determine the cost-effectiveness of insulin analogues relative to human insulin in the management of individuals with type 1 and type 2 diabetes mellitus in Canada.
CADTH recognizes that stakeholder input is an important part of the COMPUS program. Your input will assist COMPUS and the COMPUS Expert Review Committee in making recommendations toward optimal prescribing of rapid-acting and long-acting insulin analogues.
We are interested in receiving your feedback on:
Please send your feedback to compusfeedback@cadth.ca.
For additional information, please refer to our consultations page.
CADTH will be closed for the holidays from December 24, 2007 to January 1, 2008.
CADTH has many exciting job openings. The COMPUS Directorate is currently recruiting for:
If you’re interested in joining our growing team of professionals, visit Careers/Job Listings.
We welcome your feedback. Tell us what you think of the COMPUS Communiqué.